Navigation Links
Marketing and Meeting Details (M2D) Officially Launches an Innovative Life Sciences Marketing and Communications Company
Date:11/19/2007

Clients to Benefit from a Distinctive Union of Pharmaceutical, Biotech and Medical Device Experience in Professional Education, Brand Management and

Special Event Planning

NORTH BRANFORD, Conn., Nov. 19 /PRNewswire/ -- M2D management announces the official launch of a progressive marketing and communications firm that will focus on the life sciences sector. M2D is the brainchild of two individuals with clear records of success in this highly regulated sector, Christine Lawton and Timothy Roe.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071119/NEM104LOGO )

Christine is a respected meetings and events professional with almost two decades of experience working on both the client and agency sides of the business. Her accomplishments span several hundred meetings and conventions of all varieties, both domestically and internationally, during her pharmaceutical tenure.

Timothy is a pharmaceutical and medical device professional with over 15 years of progressively responsible positions in Sales and Marketing. Timothy is known in the industry as having the business acumen to maximize a product's global commercial return and asset value. Timothy has managed the "Big-C" brands, Celebrex(R), Cipro(R) and Clarinex(R) as well as several smaller niche products.

M2D provides tireless proactive thinking that eliminates problems associated with vendor complacency. Timothy Roe adds:

"As a former Product Manager, I recognize what is important to clients. Vendors should always add more detailed and proactive thought to their work, even after the 'honeymoon' period. There continues to be a tremendous need for much higher performance, and smaller firms like M2D are already there. Those who can do it cost-effectively will win."

M2D's uniqueness results from a lifetime of client-side interactions with vendors. Clients receive genuine strategic attention, but the difference lies with M2D's painstakingly detailed approach to tactical execution. The company utilizes the most advanced analytics and metric reporting tools available and offers them either gratis or at attractive pricing.

M2D's core capabilities include:

-- Thorough Understanding of Compliance Laws

-- Lowest Guaranteed Travel Rates

-- Investigator & Sales Meetings

-- Conventions & Symposia; Ad Boards & Round Tables

-- Opinion Leader & Speaker Bureau Management

-- Promotional Peer-to-Peer Events

-- CME-based Programming

-- Surrogate Brand Management and Audits

-- Advanced Webinars & Web Conferences with Real-Time Polling

M2D's website http://www.m2details.com.

Celebrex, Cipro and Clarinex are products of Pfizer, Bayer and Schering- Plough respectively.

Contact: M2D Media Relations

Phone: 781-210-4710

Fax: 781-210-4711

Email: MediaRelations@m2details.com


'/>"/>
SOURCE Marketing and Meeting Details (M2D)
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
2. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
3. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
4. Fitness Champion Natalie Waples to be Spokesperson for Natural Nutrition International Direct Marketing Campaign
5. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
6. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
7. Sterling Life Enhances Marketing Operations Controls to Better Serve Medicare Beneficiaries
8. Former Ronco President Tim Dupler Signs International Direct Sales and Marketing Contract with Natural Nutrition
9. Eastern Alliance Insurance Group Appoints Cox Regional Marketing Director for Southeast
10. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
11. Scientific Publications Strategy & Delivery Shifts from Marketing to Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... ... Coast Dental Fort Stewart is celebrating its grand opening with an open ... Mall at 112 Vilseck Road in Fort Stewart. There will be refreshments, giveaways, and ... the opportunity to meet general dentists Thomas Richards, DDS, and Josh Faulk, DMD, and ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Mobility Designed ... put pressure on the armpits, the M+D Crutch evenly distributes body weight from the ... wrists and hands when using the crutches than with other crutches. , Co-founders Max ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Robert Mondavi, one of the ... smiles. Cosmetic dentistry is a fast-growing field as more patients are discovering the many ... learn more about the options currently available to them and which ones might work ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the ... of funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... base and accelerate its technology and product roadmap. , “Jvion is ...
(Date:4/29/2016)... ... April 29, 2016 , ... The infertility specialists at HRC Fertility/Orange County ... Dr. Daniel A. Potter -- are proud of the recent release of their 2014 ... April, SART published the latest verified data for 375 U.S. member clinics. ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... Calif. , April 28, 2016  Marking ... widely accessible breast and ovarian cancer risk test, ... panel analyzing 30 genes that highly impact the ... women. Available today, the Color Test analyzes hereditary ... prostate, stomach, and uterine cancers. The Color Test ...
(Date:4/28/2016)... Dr. Vivek Ahuja , George ... phen Schmidt Join the Growing Organization ... for life sciences, today announced key new leaders have joined the ... a growing business.  This will bolster the company,s safety business unit ... ArisGlobal in the position of Vice President - Safety. George has ...
(Date:4/28/2016)... 2016 New market research ... a report that provides an overview of the ... by identifying new targets and MOAs to produce ... discussed in this H1 2016 Osteoarthritis Pipeline report ... Inc., Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, ...
Breaking Medicine Technology: